Beijing Beilu Pharmaceutical

About

Beijing Beilu Pharmaceutical mainly engaged in the research and development, production, and sales of pharmaceutical products. It is a national high-tech enterprise, one of the first batch of listed enterprises in Growth Enterprises Market (stock code 300016), and a leading contrast agent enterprise. Beilu is the first company to develop and launch the contrast agent products in China, filling the gap in the domestic market, and forming a unique core competitive advantage in this field is the market leader in the domestic contrast agent industry. In addition, the company has also strengthened R&D in the field of psychoneurosis and endocrinology drugs, and strive to achieve variety diversification.

Investment Focus

Location

Beijing, China